Yabao Pharmaceutical Group Stock Forecast for 2023 - 2025 - 2030
Updated on 05/18/2024
Yabao Pharmaceutical Group Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Yabao Pharmaceutical Group's Price has fallen from ¥9.06 to ¥0.00 – a 100.00% decrease. In the next year, analysts predict that Fair Value will reach ¥0.00 – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600276 Stock Forecast | Jiangsu Hengrui Medicine | Buy |
15
|
¥44.75 | Buy/Sell | ¥56.49 | 20.67% |
| T14 Stock Forecast | Tianjin Pharmaceutical Da Ren ... | Outperform |
18
|
$35.79 | Buy/Sell | $1.70 | 27.97% |
| 600436 Stock Forecast | Zhangzhou Pientzehuang Pharmac... | Outperform |
18
|
¥237.10 | Buy/Sell | ¥302.86 | 18.63% |
| 000538 Stock Forecast | Yunnan Baiyao Group Co.,Ltd | Outperform |
18
|
¥55.31 | Buy/Sell | ¥65.39 | 17.23% |
| 1093 Stock Forecast | CSPC Pharmaceutical Group | Buy |
18
|
HK$6.62 | Buy/Sell | HK$9.50 | 40.18% |
Yabao Pharmaceutical Group Revenue Forecast for 2023 - 2025 - 2030
Yabao Pharmaceutical Group's Revenue has grown in the last two years, jumping from ¥2.60B to ¥2.72B – an increase of 4.45%. According to 0 prominent analysts, Yabao Pharmaceutical Group's Revenue will fall by 0.82% in the next year, reaching ¥2.70B. By 2030, professionals believe that Yabao Pharmaceutical Group's Revenue will decrease by 0.78%, reaching ¥2.70B – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600085 Stock Forecast | Beijing Tongrentang | Outperform |
16
|
¥46.33 | Buy/Sell | ¥61.18 | 20.87% |
| 000999 Stock Forecast | China Resources Sanjiu Medical... | Buy |
18
|
¥61.80 | Buy/Sell | ¥65.95 | 10.26% |
| 600196 Stock Forecast | Shanghai Fosun Pharmaceutical ... | Outperform |
16
|
¥23.78 | Buy/Sell | ¥33.57 | 9.76% |
.jpg)
Yabao Pharmaceutical Group Dividend per Share Forecast for 2023 - 2025 - 2030
Yabao Pharmaceutical Group's Dividend per Share has decreased In the last two years, from ¥0.05 to ¥0.05 – a 0.00% drop. In the next year, analysts are expecting an increase in Dividend per Share, predicting it will reach ¥0.06 – an increase of 27.50%. The Yabao Pharmaceutical Group forecast is for Dividend per Share to reach ¥0.07 or grow by 32.09%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 002294 Stock Forecast | Shenzhen Salubris Pharmaceutic... | Buy |
18
|
¥29.56 | Buy/Sell | ¥35.65 | 25.17% |
| 600079 Stock Forecast | Humanwell Healthcare (Group) | Buy |
0
|
¥20.28 | Buy/Sell | ¥32.49 | -100.00% |
| 000513 Stock Forecast | Livzon Pharmaceutical Group | Outperform |
18
|
¥36.98 | Buy/Sell | ¥39.23 | 11.41% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 300146 Stock Forecast | Byhealth | Outperform |
15
|
¥15.91 | Buy/Sell | ¥26.39 | 28.85% |
| 600518 Stock Forecast | Kangmei Pharmaceutical | - |
6
|
¥1.95 | Buy/Sell | ¥25.97 | -100.00% |
| 002262 Stock Forecast | Jiangsu Nhwa Pharmaceutical Co... | Buy |
18
|
¥23.69 | Buy/Sell | ¥31.34 | 30.86% |
Yabao Pharmaceutical Group EBITDA Forecast for 2023 - 2025 - 2030
Yabao Pharmaceutical Group's EBITDA has increased by 17.95% In the last two years, going from ¥286.09M to ¥337.44M. In the next year, 0 analysts estimate that Yabao Pharmaceutical Group's EBITDA will decrease by 1.53%, reaching ¥332.27M. According to professional forecasts, in 2030, Yabao Pharmaceutical Group's EBITDA will decrease by 1.40%, reaching ¥332.72M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 900904 Stock Forecast | Shanghai Shenqi Pharmaceutical... | - |
13
|
$6.58 | Buy/Sell | $0.00 | -100.00% |
| 600062 Stock Forecast | China Resources Double-Crane P... | Buy |
16
|
¥22.64 | Buy/Sell | ¥26.00 | 13.69% |
| 600380 Stock Forecast | Joincare Pharmaceutical Group ... | Buy |
18
|
¥11.61 | Buy/Sell | ¥14.72 | 26.79% |
Yabao Pharmaceutical Group EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Yabao Pharmaceutical Group's EBIT has grown, increasing from ¥117.42M to ¥178.09M – a growth of 51.67%. According to 0 analysts, Yabao Pharmaceutical Group's EBIT will fall by 6.48% in the next year, reaching ¥166.54M. Professionals believe that By 2030, Yabao Pharmaceutical Group's EBIT will fall to ¥167.24M – a 6.09% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 002773 Stock Forecast | Chengdu Kanghong Pharmaceutica... | Buy |
11
|
¥22.71 | Buy/Sell | ¥24.00 | -100.00% |
| 600867 Stock Forecast | Tonghua Dongbao Pharmaceutical | Outperform |
18
|
¥10.08 | Buy/Sell | ¥14.25 | 41.07% |
| 603858 Stock Forecast | Shandong Buchang Pharmaceutica... | - |
18
|
¥16.85 | Buy/Sell | ¥0.00 | -100.00% |
Yabao Pharmaceutical Group EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Yabao Pharmaceutical Group's EPS has fallen from ¥0.33 to ¥0.00 – a 100.00% decrease. In the next year, analysts predict that EPS will reach ¥0.00 – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 000623 Stock Forecast | Jilin Aodong Pharmaceutical Gr... | Buy |
16
|
¥15.28 | Buy/Sell | ¥0.00 | 48.36% |
| 600422 Stock Forecast | KPC Pharmaceuticals,Inc | Buy |
18
|
¥22.64 | Buy/Sell | ¥28.00 | 10.47% |
| 000766 Stock Forecast | Tonghua Golden-Horse Pharmaceu... | - |
11
|
¥16.42 | Buy/Sell | ¥33.00 | -100.00% |
Site Navigation
.jpg)